{"id":116135,"date":"2025-09-24T17:51:08","date_gmt":"2025-09-24T08:51:08","guid":{"rendered":"https:\/\/www.hiro-clinic.or.jp\/nipt\/nipt-amniocentesis-down-syndrome\/"},"modified":"2025-09-24T17:59:25","modified_gmt":"2025-09-24T08:59:25","slug":"nipt-amniocentesis-down-syndrome","status":"publish","type":"post","link":"https:\/\/www.hiro-clinic.or.jp\/nipt\/nipt-amniocentesis-down-syndrome\/?lang=en","title":{"rendered":"Differences Between NIPT and Amniocentesis in Detecting Down Syndrome"},"content":{"rendered":"\n<p>In recent years, there has been significant advancement in prenatal diagnostic techniques, and particularly for detecting <strong>Down syndrome<\/strong>, non\u2011invasive prenatal genetic testing (<a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a>) has attracted attention. Compared to the conventional invasive test, amniocentesis, <a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a> offers higher safety and has become widely adopted as a method that reduces the burden on pregnant women. In this article, we provide a detailed explanation of the features, accuracy, advantages &amp; disadvantages, and selection criteria for <a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a> versus amniocentesis.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_84 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">\u76ee\u6b21<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/nipt-amniocentesis-down-syndrome\/?lang=en\/#1_What_Is_Down_Syndrome\" >1. What Is Down Syndrome<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/nipt-amniocentesis-down-syndrome\/?lang=en\/#2_What_Is_NIPT\" >2. What Is NIPT<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/nipt-amniocentesis-down-syndrome\/?lang=en\/#Accuracy_of_NIPT\" >Accuracy of NIPT<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/nipt-amniocentesis-down-syndrome\/?lang=en\/#Advantages_of_NIPT\" >Advantages of NIPT<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/nipt-amniocentesis-down-syndrome\/?lang=en\/#Disadvantages_of_NIPT\" >Disadvantages of NIPT<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/nipt-amniocentesis-down-syndrome\/?lang=en\/#3_What_Is_Amniocentesis\" >3. What Is Amniocentesis<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/nipt-amniocentesis-down-syndrome\/?lang=en\/#Advantages_of_Amniocentesis\" >Advantages of Amniocentesis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/nipt-amniocentesis-down-syndrome\/?lang=en\/#Disadvantages_of_Amniocentesis\" >Disadvantages of Amniocentesis<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/nipt-amniocentesis-down-syndrome\/?lang=en\/#4_Comparison_Between_NIPT_and_Amniocentesis\" >4. Comparison Between NIPT and Amniocentesis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/nipt-amniocentesis-down-syndrome\/?lang=en\/#5_Criteria_for_Choosing_the_Test\" >5. Criteria for Choosing the Test<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/nipt-amniocentesis-down-syndrome\/?lang=en\/#6_Clinical_Data_and_Research\" >6. Clinical Data and Research<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/nipt-amniocentesis-down-syndrome\/?lang=en\/#7_Ethical_and_Social_Considerations_in_NIPT_Implementation\" >7. Ethical and Social Considerations in NIPT Implementation<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/nipt-amniocentesis-down-syndrome\/?lang=en\/#8_Summary_So_Far\" >8. Summary So Far<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/nipt-amniocentesis-down-syndrome\/?lang=en\/#9_What_to_Do_After_a_Positive_NIPT_Result\" >9. What to Do After a Positive NIPT Result<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/nipt-amniocentesis-down-syndrome\/?lang=en\/#10_Points_to_Consider_When_Choosing_Between_NIPT_and_Amniocentesis\" >10. Points to Consider When Choosing Between NIPT and Amniocentesis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/nipt-amniocentesis-down-syndrome\/?lang=en\/#11_Social_Challenges_Accompanying_NIPT_Adoption\" >11. Social Challenges Accompanying NIPT Adoption<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/nipt-amniocentesis-down-syndrome\/?lang=en\/#12_NIPT_Adoption_and_Clinical_Guidelines_Around_the_World\" >12. NIPT Adoption and Clinical Guidelines Around the World<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/nipt-amniocentesis-down-syndrome\/?lang=en\/#United_States\" >United States<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/nipt-amniocentesis-down-syndrome\/?lang=en\/#Europe\" >Europe<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/nipt-amniocentesis-down-syndrome\/?lang=en\/#Japan\" >Japan<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/nipt-amniocentesis-down-syndrome\/?lang=en\/#13_Precautions_Pregnant_Women_Should_Know\" >13. Precautions Pregnant Women Should Know<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/nipt-amniocentesis-down-syndrome\/?lang=en\/#14_Extended_Summary\" >14. Extended Summary<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"1_What_Is_Down_Syndrome\"><\/span>1. What Is Down Syndrome<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Down syndrome (Trisomy 21) is a congenital chromosomal abnormality caused by having one extra copy of chromosome 21. It occurs in approximately 1 in 1,000 live births and may be associated with intellectual disability, characteristic physical features, congenital heart disease, and other conditions. With advances in prenatal diagnosis technology, it is now possible during pregnancy to detect the presence or absence of Down syndrome with high precision.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"2_What_Is_NIPT\"><\/span>2. What Is NIPT<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a> (Non\u2011Invasive Prenatal Testing) is a method that analyzes fetal-derived cell-free DNA (cfDNA) present in the mother\u2019s bloodstream to detect chromosomal abnormalities. It can be performed by drawing maternal blood after about 10 weeks of gestation, and it does not involve any direct invasive procedure on the mother or fetus. The scope of testing may include not only Down syndrome (Trisomy&nbsp;21), but also Trisomy&nbsp;18, Trisomy&nbsp;13, and potentially other chromosomal anomalies.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Accuracy_of_NIPT\"><\/span>Accuracy of NIPT<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>Multiple studies have reported that <a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a> provides very high screening accuracy for Down syndrome.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Sensitivity (True Positive Rate): \u2265 99%<\/li>\n\n\n\n<li>Specificity (True Negative Rate): \u2265 99%<\/li>\n<\/ul>\n\n\n\n<p>For example, in a report by ACOG (American College of Obstetricians and Gynecologists), for high\u2011risk pregnancies the sensitivity of <a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a> for detecting Down syndrome was 99.7%, and specificity was 99.9%. This high accuracy significantly reduces false\u2011positive and false\u2011negative rates compared with traditional serum marker screening.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Advantages_of_NIPT\"><\/span>Advantages of NIPT<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Non\u2011invasive and safe<\/strong>: Because it involves only a blood draw, the risks of miscarriage or infection are negligible<\/li>\n\n\n\n<li><strong><a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/early-nipt-august-only\/\">Early<\/a> testing possible<\/strong>: Can be done from about 10 weeks of gestation<\/li>\n\n\n\n<li><strong>High accuracy<\/strong>: Superior sensitivity and specificity compared with traditional screening<\/li>\n\n\n\n<li><strong>Simultaneous detection of multiple chromosomal abnormalities<\/strong>: Includes not only Trisomy 21 but also Trisomy 18, Trisomy 13, etc.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Disadvantages_of_NIPT\"><\/span>Disadvantages of NIPT<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Not a definitive diagnosis<\/strong>: It is only a screening test; positive results must be confirmed by invasive procedures such as amniocentesis<\/li>\n\n\n\n<li><strong>Possibility of false positives\/negatives<\/strong>: Maternal chromosomal variants, multiple pregnancies, or placental DNA contributions may lead to misclassification<\/li>\n\n\n\n<li><strong>High cost<\/strong>: Insurance coverage is often limited, so it is frequently offered as an out\u2011of\u2011pocket test<\/li>\n<\/ul>\n\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"3_What_Is_Amniocentesis\"><\/span>3. What Is Amniocentesis<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Amniocentesis is an invasive test in which a needle is inserted through the mother\u2019s abdominal wall to withdraw amniotic fluid, and the fetal chromosomes are directly analyzed. Because it is classified as an invasive procedure, there is a risk of miscarriage (approximately 0.1\u20130.3%), but it allows for a definitive diagnosis of chromosomal abnormalities.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Advantages_of_Amniocentesis\"><\/span>Advantages of Amniocentesis<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Definitive diagnosis<\/strong>: Can confirm chromosomal and genetic abnormalities with very high accuracy<\/li>\n\n\n\n<li><strong>Broad detection capability<\/strong>: Can identify fine chromosomal changes or single-gene disorders that <a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a> cannot detect<\/li>\n\n\n\n<li><strong>Detailed results<\/strong>: Able to detect structural chromosomal abnormalities or mosaicism (mosaic syndromes)<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Disadvantages_of_Amniocentesis\"><\/span>Disadvantages of Amniocentesis<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Invasive with risks<\/strong>: There is a possibility of miscarriage, infection, or rupture of membranes<\/li>\n\n\n\n<li><strong>Later testing window<\/strong>: Typically performed at 15\u201318 weeks of gestation, which is less suitable for early detection<\/li>\n\n\n\n<li><strong>Psychological and physical burden<\/strong>: The procedure may cause pain, anxiety, or discomfort<\/li>\n<\/ul>\n\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"4_Comparison_Between_NIPT_and_Amniocentesis\"><\/span>4. Comparison Between NIPT and Amniocentesis<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Feature<\/th><th><a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a><\/th><th>Amniocentesis<\/th><\/tr><\/thead><tbody><tr><td>Testing method<\/td><td>Maternal blood sampling<\/td><td>Amniotic fluid sampling (abdominal puncture)<\/td><\/tr><tr><td>Safety<\/td><td>High (non\u2011invasive)<\/td><td>Moderate (risk of miscarriage)<\/td><\/tr><tr><td>Diagnostic accuracy<\/td><td>High, but screening only<\/td><td>Can provide definitive diagnosis<\/td><\/tr><tr><td>Gestational timing<\/td><td>From ~10 weeks onward<\/td><td>Usually at 15\u201318 weeks<\/td><\/tr><tr><td>Cost<\/td><td>Often out-of-pocket, relatively high<\/td><td>Out-of-pocket or partially covered by insurance<\/td><\/tr><tr><td>Detectable abnormalities<\/td><td>Trisomy 21, 18, 13, etc.<\/td><td>Chromosomal abnormalities broadly, micro\u2011aberrations, gene-level defects<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p>As the table shows, <a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a> offers safety and early screening advantages, but amniocentesis remains essential for final diagnosis.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"5_Criteria_for_Choosing_the_Test\"><\/span>5. Criteria for Choosing the Test<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p><a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a> is generally recommended for pregnant women who meet one or more of the following criteria:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Advanced maternal age (\u2265 35 years)<\/li>\n\n\n\n<li>History of a fetus with chromosomal abnormality<\/li>\n\n\n\n<li>High-risk indication from serum marker screening<\/li>\n<\/ul>\n\n\n\n<p>Amniocentesis is selected when confirmation is needed following a positive <a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a> result, or when a specific genetic anomaly is suspected. Medical institutions decide between <a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a> and amniocentesis based on maternal age, risk profile, and patient preference.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"6_Clinical_Data_and_Research\"><\/span>6. Clinical Data and Research<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Recent studies have demonstrated the clinical utility of <a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a>.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>In a 2014 study by Bianchi et al., <a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a> was performed on 1,200 pregnant women; the detection rate for Down syndrome was 100%, and the false positive rate was 0.1%.<\/li>\n\n\n\n<li>In a 2015 report by Gil et al., among high-risk pregnancies, <a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a>&#8217;s sensitivity for Down syndrome was 99.7% and specificity was 99.9%.<\/li>\n<\/ul>\n\n\n\n<p>On the other hand, amniocentesis has long been the gold standard for definitive diagnosis, and its capacity to detect microchromosomal abnormalities still makes it highly valuable in certain special cases.<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full\"><img decoding=\"async\" width=\"640\" height=\"480\" src=\"\/nipt\/wp-content\/uploads\/2025\/09\/32744813_s-5.webp\" alt=\"\u533b\u7642\" class=\"wp-image-116129\"\/><\/figure><\/div>\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"7_Ethical_and_Social_Considerations_in_NIPT_Implementation\"><\/span>7. Ethical and Social Considerations in NIPT Implementation<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Because <a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a> is non-invasive and safe, its demand is increasing. However, the interpretation of test results and decision-making require caution. A positive result may cause psychological stress to the pregnant woman and her family. It is important to understand that <a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a> is <strong>not<\/strong> a definitive diagnosis and to consult with medical professionals when making decisions.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"8_Summary_So_Far\"><\/span>8. Summary So Far<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Prenatal diagnosis of Down syndrome can use two main approaches: <a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a> (non-invasive screening) and amniocentesis (invasive definitive diagnosis).<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a> enables early, safe, and high-precision screening but cannot provide a definitive diagnosis<\/li>\n\n\n\n<li>Amniocentesis allows for definitive diagnosis and broader chromosomal analysis but carries miscarriage risk<\/li>\n<\/ul>\n\n\n\n<p>Choosing the appropriate test requires considering gestational age, risk tolerance, diagnostic objectives, cost, and medical support. Having a clear understanding of the differences between <a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a> and amniocentesis is a crucial first step for pregnant women and their families to maintain a reassuring and informed pregnancy journey.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"9_What_to_Do_After_a_Positive_NIPT_Result\"><\/span>9. What to Do After a Positive NIPT Result<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Although <a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a> offers high screening accuracy, a positive result requires confirmation. The general pathway is as follows:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Genetic Counseling<\/strong><br>A genetic specialist or counselor explains the meaning of the test result, the accuracy and risks of further testing, and provides psychological support so the pregnant woman and family can make informed decisions.<\/li>\n\n\n\n<li><strong>Choose a Definitive Diagnostic Test<\/strong><br>Perform amniocentesis or chorionic villus sampling to confirm whether fetal chromosomal abnormalities exist. Amniocentesis is typically done after 15 weeks of gestation, though some medical centers may recommend it around 16 weeks.<\/li>\n\n\n\n<li><strong>Decision Based on Diagnostic Outcome<\/strong><br>Based on the confirmed results, the pregnant woman and family consider whether to continue the pregnancy and plan medical or educational support after birth. If Down syndrome is confirmed, early intervention and preparation of medical and support systems are important.<\/li>\n<\/ol>\n\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"10_Points_to_Consider_When_Choosing_Between_NIPT_and_Amniocentesis\"><\/span>10. Points to Consider When Choosing Between NIPT and Amniocentesis<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>When a pregnant woman is to decide on the test method, it is recommended to weigh the following:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Gestational age<\/strong>: <a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a> is possible from about 10 weeks; amniocentesis is usually between 15\u201318 weeks<\/li>\n\n\n\n<li><strong>Risk tolerance<\/strong>: Amniocentesis carries miscarriage risk, so the woman\u2019s comfort with that risk is important<\/li>\n\n\n\n<li><strong>Purpose of testing<\/strong>: If high-precision screening suffices, <a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a> may be enough; if definitive diagnosis is required, amniocentesis is needed<\/li>\n\n\n\n<li><strong>Cost and insurance coverage<\/strong>: In many countries <a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a> is self-pay and may cost tens of thousands to over a hundred thousand (local currency), while amniocentesis may have partial insurance coverage<\/li>\n<\/ul>\n\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"11_Social_Challenges_Accompanying_NIPT_Adoption\"><\/span>11. Social Challenges Accompanying NIPT Adoption<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>Although the spread of <a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a> reduces burdens and enhances reassurance for pregnant women, several social and ethical issues arise:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Pressure from widespread testing<\/strong><br>Because <a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a> is simple and non-invasive, there is risk of societal pressure making it seem \u201cmandatory.\u201d<\/li>\n\n\n\n<li><strong>Importance of information disclosure<\/strong><br>Since <a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a> is not definitive, healthcare providers must carefully explain results to avoid misunderstandings.<\/li>\n\n\n\n<li><strong>Balance between prenatal testing and disability support<\/strong><br>As prenatal detection expands, birth rates of conditions like Down syndrome may decline, increasing the importance of robust medical, educational, and welfare systems for those born with such conditions. Finding balance between technical progress and social support is a continuous challenge.<\/li>\n<\/ul>\n\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"12_NIPT_Adoption_and_Clinical_Guidelines_Around_the_World\"><\/span>12. NIPT Adoption and Clinical Guidelines Around the World<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"United_States\"><\/span>United States<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>ACOG recommends offering <a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a> to all pregnant women, not just those at high risk, but emphasizes that positive results require confirmatory diagnosis.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Europe\"><\/span>Europe<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>In countries such as the UK and France, <a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a> may be provided under public health insurance as a screening method and is used prior to invasive diagnostic testing.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Japan\"><\/span>Japan<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p>In Japan, <a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a> is typically limited to women 35 or older or those with higher risk, and it is performed as a self\u2011pay service. Amniocentesis is used as a diagnostic procedure based on physician judgment.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"13_Precautions_Pregnant_Women_Should_Know\"><\/span>13. Precautions Pregnant Women Should Know<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Testing is voluntary<\/strong><br>Both <a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a> and amniocentesis are optional, and the pregnant woman\u2019s choice must be respected.<\/li>\n\n\n\n<li><strong>Understand the meaning of positive\/negative results<\/strong><br><a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a> is a screening tool; a negative result does not guarantee absence of abnormality, and a positive result requires confirmatory testing.<\/li>\n\n\n\n<li><strong>Seek family support<\/strong><br>The choice and interpretation of tests can impose psychological stress; support from family and healthcare professionals is important.<\/li>\n\n\n\n<li><strong>Choose a reliable medical institution<\/strong><br>While <a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a> is highly accurate, the quality and experience of the testing institution can vary. It is advisable to use certified or accredited providers.<\/li>\n<\/ul>\n\n\n\n<p><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"14_Extended_Summary\"><\/span>14. Extended Summary<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>There are two principal approaches to prenatal diagnosis of Down syndrome: <a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a> and amniocentesis.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a>: non-invasive, safe, allows early high-precision screening<\/li>\n\n\n\n<li>Amniocentesis: provides definitive diagnosis and can analyze broader chromosomal abnormalities<\/li>\n<\/ul>\n\n\n\n<p>When selecting a testing method, pregnant women should consider gestational age, risk tolerance, diagnostic purpose, cost, and the available medical infrastructure. Crucially, the interpretation of test results and subsequent decisions require support from genetic counseling and healthcare professionals. As prenatal diagnostic options increase, understanding the difference between <a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/\">NIPT<\/a> and amniocentesis is the first step toward a confident and informed pregnancy experience.<\/p>\n","protected":false},"excerpt":{"rendered":"In recent years, the&#8230;\n <a href=\"https:\/\/www.hiro-clinic.or.jp\/nipt\/nipt-amniocentesis-down-syndrome\/?lang=en\">\u7d9a\u304d\u3092\u8aad\u3080<\/a>","protected":false},"author":122,"featured_media":116125,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[97],"tags":[],"class_list":["post-116135","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.hiro-clinic.or.jp\/nipt\/wp-json\/wp\/v2\/posts\/116135","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hiro-clinic.or.jp\/nipt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hiro-clinic.or.jp\/nipt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hiro-clinic.or.jp\/nipt\/wp-json\/wp\/v2\/users\/122"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hiro-clinic.or.jp\/nipt\/wp-json\/wp\/v2\/comments?post=116135"}],"version-history":[{"count":2,"href":"https:\/\/www.hiro-clinic.or.jp\/nipt\/wp-json\/wp\/v2\/posts\/116135\/revisions"}],"predecessor-version":[{"id":116152,"href":"https:\/\/www.hiro-clinic.or.jp\/nipt\/wp-json\/wp\/v2\/posts\/116135\/revisions\/116152"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.hiro-clinic.or.jp\/nipt\/wp-json\/wp\/v2\/media\/116125"}],"wp:attachment":[{"href":"https:\/\/www.hiro-clinic.or.jp\/nipt\/wp-json\/wp\/v2\/media?parent=116135"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hiro-clinic.or.jp\/nipt\/wp-json\/wp\/v2\/categories?post=116135"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hiro-clinic.or.jp\/nipt\/wp-json\/wp\/v2\/tags?post=116135"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}